These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14676066)

  • 1. Parkinson disease with old-age onset.
    Jellinger KA
    Arch Neurol; 2003 Dec; 60(12):1814-5. PubMed ID: 14676066
    [No Abstract]   [Full Text] [Related]  

  • 2. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of late-onset Parkinson disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    Arch Neurol; 2003 Dec; 60(12):1815-6; reply 1816. PubMed ID: 14676067
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Parkinsonism Relat Disord; 2009 Feb; 15(2):153-5. PubMed ID: 18514013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival in dementia with lewy bodies and Parkinson dementia.
    Jellinger KA; Wenning GK; Seppi K
    Neurodegener Dis; 2007; 4(6):428-30. PubMed ID: 17934326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.
    Voon V; Thomsen T; Miyasaki JM; de Souza M; Shafro A; Fox SH; Duff-Canning S; Lang AE; Zurowski M
    Arch Neurol; 2007 Feb; 64(2):212-6. PubMed ID: 17296836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease?
    Papapetropoulos S; Singer C; Villar JM; Gonzalez J; Mash DC
    Mov Disord; 2005 May; 20(5):641-2. PubMed ID: 15747366
    [No Abstract]   [Full Text] [Related]  

  • 9. Body mass index and the risk of Parkinson disease.
    Ikeda K; Kashihara H; Tamura M; Kano O; Iwamoto K; Iwasaki Y
    Neurology; 2007 Jun; 68(24):2156; author reply 2156-7. PubMed ID: 17562841
    [No Abstract]   [Full Text] [Related]  

  • 10. Smoking and tea consumption delay onset of Parkinson's disease.
    Kandinov B; Giladi N; Korczyn AD
    Parkinsonism Relat Disord; 2009 Jan; 15(1):41-6. PubMed ID: 18434232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
    Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
    J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of inter-observer reliability in the use of qualitative scales assessing Parkinson disease (II)].
    Martínez-Martín P; Carrasco de la Peña JL; Ramo C; Antigüedad AR; Bermejo F
    Arch Neurobiol (Madr); 1988; 51(5):287-91. PubMed ID: 3219024
    [No Abstract]   [Full Text] [Related]  

  • 13. Family history of dementia in early-onset versus very late-onset Alzheimer's disease.
    McMurtray AM; Ringman J; Chao SZ; Licht E; Saul RE; Mendez MF
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):597-8. PubMed ID: 16783800
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
    Carod-Artal FJ; Martinez-Martin P; Vargas AP
    Mov Disord; 2007 Jan; 22(1):91-8. PubMed ID: 17094102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
    Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.
    Reuther M; Spottke EA; Klotsche J; Riedel O; Peter H; Berger K; Athen O; Köhne-Volland R; Dodel RC
    Parkinsonism Relat Disord; 2007 Mar; 13(2):108-14. PubMed ID: 17055326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of joint disorders in Parkinson's disease and their impact on health status.
    Natalwala A; Davies P; Buckley CD; Potluri R; Clarke CE
    J Clin Neurosci; 2009 Oct; 16(10):1382-3. PubMed ID: 19576783
    [No Abstract]   [Full Text] [Related]  

  • 20. Handedness as a predictor of side of onset of Parkinson's disease.
    Yust-Katz S; Tesler D; Treves TA; Melamed E; Djaldetti R
    Parkinsonism Relat Disord; 2008 Dec; 14(8):633-5. PubMed ID: 18346926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.